Your browser doesn't support javascript.
loading
Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol.
Han, ShaoWei; Deng, ZiJie; Cheung, KaShing; Lyu, Tao; Chan, PuiLing; Li, Ying; Ni, Li; Luo, XiaPeng; Li, Kuan.
Affiliation
  • Han S; Shantou University Medical College, Shantou, China.
  • Deng Z; Department of Pharmacy, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Cheung K; Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Lyu T; Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Chan P; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
  • Li Y; Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Ni L; Department of Pharmacy, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Luo X; Department of Pharmacy, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Li K; Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
BMC Gastroenterol ; 23(1): 231, 2023 Jul 07.
Article in En | MEDLINE | ID: mdl-37420205
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Helicobacter pylori / Helicobacter Infections Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Helicobacter pylori / Helicobacter Infections Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Humans Language: En Year: 2023 Type: Article